Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 AB INBEV ABI May 25, 2022 52.36 +2.53   
 ABO-Group ABO May 25, 2022 5.15 +0.98   
 Acacia Pharma Group Plc ACPH May 25, 2022 0.86 +2.63   
 Accentis S.A. ACCB May 25, 2022 0.07 0.00   
 Ackermans & van Haaren NV ACKB May 25, 2022 160.00 -0.19   
 Aedifica SA AED May 25, 2022 108.40 +0.18   
 Ageas AGS May 25, 2022 45.48 -0.13   
 AGFA-Gevaert NV AGFB May 25, 2022 3.84 -1.03   
 AHOLD DEL AD May 25, 2022 25.34 +1.14   
 Antares Certificates ANT May 25, 2022 7.00 0.00   
 APERAM APAM May 25, 2022 36.38 +1.99   
 Argen X SE ARGX May 25, 2022 293.80 -0.03   
 Ascencio Sca ASC May 25, 2022 51.70 +1.37   
 ASIT biotech SA ASIT May 25, 2022 0.23 0.00   
 Assicurazioni Generali SpA GEN May 25, 2022 17.45 0.00   
 Atenor ATEB May 25, 2022 55.20 -1.08   
 AVANTIUM AVTX May 25, 2022 3.14 +1.95   
 Azelis Group NV AZE May 25, 2022 22.84 0.00   
 Balta Group N.V. BALTA May 25, 2022 2.49 +0.40   
 Banco Bilbao Vizcaya Argentaria SA BBV May 25, 2022 4.89 0.00   
 Banco Santander SA SANTA May 25, 2022 2.95 +1.13   
 Banimmo BANI May 25, 2022 4.46 +2.29   
 Banque Nationale de Belgique BNB May 25, 2022 1 665.00 +0.60   
 Barco NV BAR May 25, 2022 20.98 -0.29   
 Basilix BAS May 25, 2022 11.52 0.00   
 Beaulieu Av Certificates BEAB May 25, 2022 5.20 -16.13   
 Befimmo SA BEFB May 25, 2022 46.75 -0.21   
 Bel20 BEL20 May 25, 2022 3 912.25 +0.50   
 Belreca - Belgian Resources and Capital Company BELR May 25, 2022 6.25 0.00   
 Beluga BELU May 25, 2022 2.52 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+